The University of Warwick Library - WebBridge
Final safety and efficacy analysis of the specific endothelin A receptor antagonist zibotentan (ZD4054) in patients with metastatic castration-resistant prostate cancer and bone metastases who were pain-free or mildly symptomatic for pain: a double-blind, placebo-controlled, randomized Phase II trial
James,
Nicholas D..
BJU International.
v.
106.
no.
7.
2010.
p.
966 -
973...
issn:
1464-1603
.
Sorry - based on the information provided, WebBridge cannot offer appropriate links.